Who Owns GeneDx Stock?
NASDAQ: WGSHealth CareMedical/Nursing ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 105.55%
- Institutions (% of float)
- 114.69%
- Held by insiders
- 7.97%
- Institutional holders
- 299
- Institutions 92.0%
- Insiders 8.0%
- Public and other 0.0%
Who owns GeneDx stock?
Institutional investors own about 105.5% of GeneDx's shares, spread across 299 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 7.97% of WGS.
The largest institutional holders are Corvex Management LP (15.96%), Casdin Capital, LLC (12.37%) and ARK Investment Management, LLC (6.38%). Together, the top 10 institutions control 63.2% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their WGS positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of WGS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Corvex Management LP | 4.78M | 15.96% | +48.2% |
| Casdin Capital, LLC | 3.71M | 12.37% | +23.3% |
| ARK Investment Management, LLC | 1.91M | 6.38% | +18.8% |
| Blackrock Inc. | 1.69M | 5.65% | -0.7% |
| Goldman Sachs Group Inc | 1.67M | 5.57% | +25.1% |
| William Blair Investment Management, LLC | 1.56M | 5.21% | +11.4% |
| Morgan Stanley | 1.01M | 3.39% | +2.7% |
| Vanguard Capital Management LLC | 948.76K | 3.17% | +7.9% |
| Citadel Advisors Llc | 865.46K | 2.89% | +33.7% |
| First Light Asset Management, LLC | 783.92K | 2.62% | +222.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of WGS
| Fund | Shares | % Held |
|---|---|---|
| ARK ETF Trust-ARK Innovation ETF | 924.53K | 3.08% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 607.77K | 2.03% |
| ARK ETF Trust-ARK Genomic Revolution ETF | 533.97K | 1.78% |
| iShares Trust-iShares Russell 2000 ETF | 518.24K | 1.73% |
| MUTUAL FUND SERIES TRUST-Eventide Gilead Fund | 266.04K | 0.89% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 249.89K | 0.83% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 220.06K | 0.73% |
| Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND | 201.67K | 0.67% |
| iShares Trust-iShares Russell 2000 Growth ETF | 186.95K | 0.62% |
| abrdn Healthcare Opportunities Fund | 171.64K | 0.57% |
Frequently asked questions
Who is the largest shareholder of GeneDx?
Corvex Management LP is the largest institutional shareholder of WGS, owning 15.96% of shares outstanding (4.78M shares) as of its latest 13F filing.
What percentage of GeneDx is owned by institutions?
Institutions own about 105.5% of WGS shares and 114.7% of the public float.
How much of GeneDx do insiders own?
Insiders, such as officers and directors, own about 7.97% of WGS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.